With reference to intimation dated August 08, 2026, Advanced Enzyme Technologies has informed that the Company has completed the acquisition of additional stake of 1.22% in JC Biotech Private Limited, subsidiary [JCB] by way of purchase of 2,53,297 Equity Shares from few selling shareholders of JCB, for a consideration of ? 22.80 million i.e. ? 90 per Equity Share. In view of this, the shareholding of the Company in JCB has increased from 95.72% to 96.94% of paid-up share capital of JCB effective from November 18, 2026. Further, the Company is in the process of acquiring the remaining 3.06% equity stake in JCB. Upon completion of the said acquisition, JCB will become a Wholly Owned Subsidiary of the Company.
The above information is a part of company’s filings submitted to BSE.